January 2016 Travel Grants

Travel Grant recipients tell about the conference

Hila Schwartz

MD.PhD student

Neta Erez's Lab

Department of Pathology, Sackler Faculty of Medicine

The Function of Tumor Microenvironment in Cancer Progression

January 7 - 10, 2016
Hard Rock Hotel
San Diego, California, USA

 

 

It was a great privilege to participate in the recent AACR meeting: “The Function of Tumor Microenvironment in Cancer Progression”, held in San Diego, California, USA,

The conference covered cutting edge research in pancreatic cancer, breast cancer and melanoma, and shed light on the complexity of interactions between cancer cells and cells of the microenvironment. In my opinion, the main contribution to cancer research was the novel in vivo models that were developed to study immune-checkpoint blockade in a clinically relevant setting, aiming at understanding the function of T cells in tumor biology.  My PhD project is focused on the role of astrocytes in promoting melanoma brain metastases. The poster sessions were very successful and interesting. I had the opportunity to discuss my work with different scientists and to be inspired by new ideas for my future experiments.  I would like to thank the CBRC for the support in attending this insightful conference. 

 

 

Dvir Netanely

PhD Student

Prof. Ron Shamir's computational genomics lab

School of Computer Science, Tel Aviv University

 

Basic Epigenetic Mechanisms in Cancer

November 8-11, 2015

Berlin, Germany

I wish to thank the CBRC for granting me a travel fellowship that allowed me to attend the "Basic Epigenetic Mechanisms in Cancer" meeting held in Germany on November 2015. The meeting was part of a conference series organized by the European association for cancer research. During the meeting, several lectures provided a thorough review of the emerging field of cancer epigenetics, while other lectures focused on specific epigenetic mechanisms and how they are involved in various types of cancer. Epigenetic alternations are just as common as genetic alternations in human cancers, and extending our understanding of these changes is expected to yield novel epigenetic biomarkers and therapeutic targets.

Personally, the topic of cancer epigenetics was of great interest for me since it is highly relevant to my work on improving breast cancer classification based on multi-omic data. Furthermore, during the meeting, I had the opportunity to hear many interesting talks from major researchers in the field speaking about their results. I have extended my knowledge in a way that would help me interpret my results regarding subtype specific epigenetics changes characterizing breast cancer development. In addition, during the poster session, I had the opportunity to discuss the results of my ongoing research with other researchers working on breast cancer research in a friendly atmosphere. Therefore, I would like to thank the CBRC for providing me this wonderful opportunity.

 

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive